[Thromboembolism in non-rheumatic atrial fibrillation]

Beta-blocker therapy after acute coronary syndrome in patients without heart failure or reduced ejection fraction: A target-trial emulation study.

European journal of preventive cardiology·2026

The safety of available pharmacotherapy for stroke prevention in atrial fibrillation.

Expert opinion on drug safety·2024

ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.

International journal of cardiology·2023

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.

International journal of cardiology·2020

An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS).

Lupus·2019

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns.

Thrombosis research·2018

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

Haematologica·2026

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Haematologica·2026

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Haematologica·2026

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Haematologica·2026

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

Haematologica·2026

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Haematologica·2026

Managing Acute STEMI in the Setting of Immune Thrombocytopenic Purpura: A Therapeutic Dilemma.

JACC. Case reports·2026

Staged matrix and micrografting reconstruction for no-option CLTI: A case report.

Science progress·2026

Management of Acute Coronary Syndromes: Is the Yentl Syndrome Vanishing?

Journal of the American Heart Association·2026

Golidocitinib as salvage therapy before allogeneic hematopoietic stem cell transplantation in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Haematologica·2026

Unmasking coronary embolism: rare non-atherosclerotic causes of acute coronary syndrome in the young: case series.

European heart journal. Case reports·2026

Fatal Delayed Stent-edge Rupture Confirmed by Autopsy after Stent-assisted Coil Embolization for a Blood Blister-like Aneurysm.

NMC case report journal·2026

Related Experiment Videos

[Thromboembolism in non-rheumatic atrial fibrillation]

Related Concept Videos

Beta-blocker therapy after acute coronary syndrome in patients without heart failure or reduced ejection fraction: A target-trial emulation study.

The safety of available pharmacotherapy for stroke prevention in atrial fibrillation.

ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.

An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS).

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns.

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Managing Acute STEMI in the Setting of Immune Thrombocytopenic Purpura: A Therapeutic Dilemma.

Staged matrix and micrografting reconstruction for no-option CLTI: A case report.

Management of Acute Coronary Syndromes: Is the Yentl Syndrome Vanishing?

Golidocitinib as salvage therapy before allogeneic hematopoietic stem cell transplantation in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Unmasking coronary embolism: rare non-atherosclerotic causes of acute coronary syndrome in the young: case series.

Fatal Delayed Stent-edge Rupture Confirmed by Autopsy after Stent-assisted Coil Embolization for a Blood Blister-like Aneurysm.

Related Experiment Videos

[Thromboembolism in non-rheumatic atrial fibrillation]

Related Concept Videos

Related Articles